NCT02232802View on ClinicalTrials.gov

Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 4, 2014

Primary Completion Date

December 5, 2014

Study Completion Date

December 5, 2014

Conditions
Enoxaparin Sodium is Administered to Healthy Volunteers
Interventions
DRUG

Enoxaparin Sodium

comparison of bioavailability of generic Enoxaparin Sodium and Clexane

DRUG

Enoxaparin Sodium

comparison of bioavailability of generic Enoxaparin Sodium and Clexane

Trial Locations (1)

CF48 4DR

Simbec Research Ltd, Merthyr Tydfil

All Listed Sponsors
lead

Chemi S.p.A.

INDUSTRY

NCT02232802 - Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c. | Biotech Hunter | Biotech Hunter